Supplement's IBS Treatment Claim Fails UK Review Following J&J Ltd. Complaint
Executive Summary
EnteroMed fails to provide adequate support for ad claims that its supplement gel absorbs toxins and treats gastrointestinal issues, including IBS, the UK Advertising Standards Authority says. A J&J UK subsidiary marketing competing consumer health products was among the complainants about the firm's ads.